Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice RAGE in Acute Pulmonary Inflammation
2011

How RAGE Affects E. coli Pneumonia in Mice

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lasse Ramsgaard, Judson M. Englert, Michelle L. Manni, Pavle S. Milutinovic, Julia Gefter, Jacob Tobolewski, Lauren Crum, Gina M. Coudriet, Jon Piganelli, Ruben Zamora, Yoram Vodovotz, Jan J. Enghild, Tim D. Oury

Primary Institution: University of Pittsburgh School of Medicine

Hypothesis

Does the receptor for advanced glycation end-products (RAGE) influence lung inflammation during E. coli pneumonia?

Conclusion

Lack of RAGE in the lung does not protect against LPS-induced acute pulmonary inflammation, but reduces injury following live E. coli challenge.

Supporting Evidence

  • RAGE KO mice had significantly less inflammation when challenged with E. coli compared to wild type mice.
  • Most cytokine levels were lower in the BALF of RAGE KO mice after E. coli injury.
  • Neither i.p. nor i.t. administration of mouse soluble RAGE attenuated the severity of E. coli injury in wild type mice.

Takeaway

This study found that mice without a specific receptor (RAGE) had less lung inflammation when infected with E. coli compared to normal mice.

Methodology

The study used wild type and RAGE knockout mice to assess inflammation after E. coli and LPS challenges.

Limitations

The study primarily focused on a single time point and specific bacterial challenges, which may not represent all forms of lung injury.

Participant Demographics

Only male C57BL/6 mice were used in the experiments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0020132

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication